Affectivity Norris Scale · people with a primary brain tumour
1 finding from 1 review
Apathy Marin Scale · people with a primary brain tumour
1 finding from 1 review
Depressive symptoms · people with a primary brain tumour
1 finding from 1 review
Health‐related quality of life European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ‐C30). Scale from: 0 to 100 (a higher score means a better outcome) · people with a primary brain tumour
1 finding from 1 review
Quality of life EORTC QLQ‐BN 20 · people with a primary brain tumour
1 finding from 1 review
Fatigue · people with a primary brain tumour
1 finding from 1 review
Fatigue –reduced motivation Subscale from CIS · people with a primary brain tumour
1 finding from 1 review
Cognition Symbol Digit Modalities Test (median (range)) · people with a primary brain tumour
1 finding from 1 review
Quality of life, self‐rated at post‐treatment · people with a primary brain tumour
1 finding from 1 review
Adverse events (grade ≥ 3) · people with a primary brain tumour
1 finding from 1 review
Fatigue –reduced activity Subscale from CIS · people with a primary brain tumour
1 finding from 1 review
Fatigue –severity Subscale from CIS · people with a primary brain tumour
1 finding from 1 review
Adverse events ( · people with a primary brain tumour
It is very uncertain whether boele 2013: modafinil changes adverse events ( compared with placebo (very low certainty).
1 finding from 1 review
Fatigue · people with a primary brain tumour
2 findings from 1 review
Cognition Trail Making Test A · people with a primary brain tumour
1 finding from 1 review
Cognition Trail Making Test B · people with a primary brain tumour
1 finding from 1 review
Falls · people with Parkinson's disease
Summary of findings for exercise probably leads to lower rate of Falls (falls per person‐year) compared with control (moderate certainty).
1 finding from 1 review
Quality of life immediately after the intervention · people with Parkinson's disease
1 finding from 1 review
Rate of adverse events excluding falls (per person year) · people with Parkinson's disease
Summary of findings for cholinesterase inhibitors may leads to higher rate of adverse events excluding falls (per person year) compared with placebo (low certainty).
1 finding from 1 review
Economic outcomes · people with Parkinson's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found